S1 EP2: Potential Treatment Options with a Focus on Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors in Patients with Heart Failure with Preserved Ejection Fraction

We are joined by Professor Michael Böhm. He is the director of the Clinic for Internal Medicine III and Chief of Cardiology at the University of the Saarland in Germany. He has a special interest in pathophysiology and treatment of heart failure and has been the principal investigator of several multicentre clinical trials. He has written more than 700 original papers, book chapters and review articles and is a past president of the German Society of Cardiology. For this episode, we will expl...

Episode 5 - The use of SGLT2 inhibitors in patients hospitalised for acute heart failure - Prof. Christiane Angermann We are joined by Professor Christiane Angermann. Prof Angermann is a Senior Professor of Medicine and Clinical Research in Cardiology at the University and University Hospital Würzburg in Germany, and co-founder of the Comprehensive Heart Failure Centre Würzburg (CHFC). She acted as coordinating investigator in the Executive Committee of the EMPULSE trial, a multinational clin...

Episode 4 - Treatment options in patients with heart failure across the spectrum of left ventricular ejection fraction with a particular interest in the pooling of previous results to gain greater insight. - Dr. Milton Packer We are joined by Dr. Milton Packer. He is a Distinguished Scholar in Cardiovascular Science at Baylor University Medical Center, Dallas in the United States. He is also a visiting professor at Imperial College London. He is one of the world leaders in the field of heart ...

We are joined by Professor Javed Butler, Chair of the Department of Medicine at University of Mississippi Medical Center in Jackson, Mississippi, United States. His main area of research is heart failure, a topic on which he’s authored more than 650 peer-reviewed publications. In the last episode, we discussed some promising results in the EMPEROR-Preserved trials where empagliflozin was shown to benefit patients with preserved ejection fraction. In this podcast, we will discuss the benefits ...

In this episode, we are joined by Professor Stefan Anker. Professor Anker is based at the Department of Cardiology, Charité Campus Virchow Clinic in Berlin, Germany. He is the principal investigator for the EMPEROR-Preserved study which is investigating the outcomes in patients with heart failure with preserved ejection fraction. In this episode, we will gain an insight into heart failure and briefly discuss some of the promising treatment options available to patients. Reference link:...